Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (191-200 of 305) with videos related to

Pageof 31
Sort By:
Neuro-Oncology|October 17, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapyTimothy F Cloughesy, Jan Drappatz, John de Groot, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Neuro-Oncology|February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomasS Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Journal of Neuro-Oncology|July 20, 2022
The landscape of brain tumor mimics in neuro-oncology practiceLalanthica V Yogendran, Tuba Kalelioglu, Joseph H Donahue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibitionYing Zhang, Kaitlyn E Farenholtz, Yanzhi Yang, et al.
British Journal of Haematology|February 28, 2014
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphomaChen Lossos, Soley Bayraktar, Elizabeth Weinzierl, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Pageof 31

Showing results (191-200 of 305) with videos related to

Sort By:
Pageof 31
Neuro-Oncology|October 17, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapyTimothy F Cloughesy, Jan Drappatz, John de Groot, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Neuro-Oncology|February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomasS Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Journal of Neuro-Oncology|July 20, 2022
The landscape of brain tumor mimics in neuro-oncology practiceLalanthica V Yogendran, Tuba Kalelioglu, Joseph H Donahue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibitionYing Zhang, Kaitlyn E Farenholtz, Yanzhi Yang, et al.
British Journal of Haematology|February 28, 2014
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphomaChen Lossos, Soley Bayraktar, Elizabeth Weinzierl, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Pageof 31